The Hiroshima study on atherosclerosis and cardiovascular disease in atomic bomb survivors

The Hiroshima study on atherosclerosis and cardiovascular disease in atomic bomb survivors - Hiroshima ACA study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052873

Enrollment

7120

Registered

2024-12-15

Start date

2023-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular disease, Type 2 diabetes mellitus, Hypertension, Hyperlipidemia, Renal dysfunction

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Participants were recruited after undergoing general health examinations at the Health Management and Promotion Center of the Hiroshima Atomic Bomb Casualty Council.

Exclusion criteria

Exclusion criteria: Health checkup participants who did not consent to the use of test results for research.

Design outcomes

Primary

Measure	Time frame
Progression of atherosclerosis	—

Secondary

Measure	Time frame
1. Incidence of cardiovascular disease 2. Incidence of hypertension 3. Incidence of diabetes 4. Incidence of renal dysfunction 5. Other cardiovascular risk factors 6. Cardiovascular death	—

Countries

Japan

Contacts

Public ContactTomomi Fujita

Hiroshima Atomic Bomb Casualty Council Health Management and Promotion Center

t-ikyoku@gentaikyo.or.jp082-243-2451

Outcome results